Novo Nordisk Foundation is funding a new and improved vaccine for respiratory diseases, such as Tuberculosis and the flu
Both Pfizer's Pacdev and Merck's Keytruda gain FDA approval as first line treatment for bladder cancer
GSK has more positive data to report in endometrial cancer
Organon, Merck's women's health-focused spinoff, has acquired rights to distribute and promote migraine medicines overseas
Merck has tapped artificial intelligence developer, Owkin, to assemble new digital diagnostic devices for cancer testing
Merck receives another FDA rejection for its chronic cough drug
Merck's kidney cancer drug receives FDA approval for a much larger patient population
%402x.svg){kind=icon}
.png)
%402x.svg){kind=icon}
